Optase Allegro

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Optase Allegro
Generic name: HYDROXYETHYL CELLULOSE
Manufacturer: Scope Health Inc
Product type: HUMAN OTC DRUG
SPL set ID: f7999928-f5c1-98d6-e053-6294a90a57db
SPL ID: 496c9402-c88e-6028-e063-6394a90a6b3c
Version: 5
Effective date: 2026-01-27
Source export date: 2026-10-12
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/f40eac55ff4c5d55c3d8bbc5766ea7e21e4196960cfb4703b96a406b491c0cd5/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:31:59

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M018	openfda.application_number
brand name		Optase Allegro	openfda.brand_name
generic name		HYDROXYETHYL CELLULOSE	openfda.generic_name
manufacturer name		Scope Health Inc	openfda.manufacturer_name
ndc	package	72972-006-01	openfda.package_ndc
ndc	product	72972-006	openfda.product_ndc
ndc11	package	72972000601	derived:openfda.package_ndc
spl id		496c9402-c88e-6028-e063-6394a90a6b3c	id
spl set id		f7999928-f5c1-98d6-e053-6294a90a57db	set_id
unii		8136Y38GY5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. • If solution changes color or becomes cloudy, do not use. To avoid contamination, do not touch tip to any surface. After use, shake the bottle downwards in order to remove any residual drop that may be left. Replace cap after using. Stop use and ask doctor if: Stop use and ask doctor if • You feel eye pain. • Changes in vision occur. • Redness or irritation of the eye lasts. • Condition worsens or lasts more than 72 hours

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.